UBE2L6 and metastatic malignant neoplasm in the lymph nodes: As seen with ISG15, UBE2L6 mRNA expression levels negatively correlated with survival in patients with cancer that had spread to the lymph nodes whereas the correlation was lost in patients without lymph node metastasis (Fig. 1D).